Long-Term Proton Pump Inhibitor Use and Gastric Cancer Risk: Interpreting Population-Based Evidence
Gut and Liver · 15.07.2026 · 20 (4) · 497-498
DOI: 10.5009/gnl260247 ↗Kurz gefasst
Editorial in der Zeitschrift Gut and Liver, erschienen am 15.07.2026. Verfasst von Hae Won Yoo. Beteiligte Einrichtung: Digestive Disease Center and Research Institute, Department of Internal Medicine, Soonchunhyang University Bucheon Hospital, Soonchunhyang University…. Die Arbeit nennt 10 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Digestive Disease Center and Research Institute, Department of Internal Medicine, Soonchunhyang University Bucheon Hospital, Soonchunhyang University College of Medicine, Bucheon, Korea.
ORCID-Profile: Hae Won Yoo
Zitieren
APA
Yoo, H. W. (2026). Long-Term Proton Pump Inhibitor Use and Gastric Cancer Risk: Interpreting Population-Based Evidence. Gut and Liver, 20(4), 497-498. https://doi.org/10.5009/gnl260247
Vancouver
Yoo HW. Long-Term Proton Pump Inhibitor Use and Gastric Cancer Risk: Interpreting Population-Based Evidence. Gut and Liver. 2026;20(4):497-498. doi:10.5009/gnl260247
BibTeX
@article{Yoo2026,
author = {Yoo, Hae Won},
title = {Long-Term Proton Pump Inhibitor Use and Gastric Cancer Risk: Interpreting Population-Based Evidence},
journal = {Gut and Liver},
year = {2026},
volume = {20},
number = {4},
pages = {497--498},
doi = {10.5009/gnl260247}
}
EUVIMED